Researchers show that glycoRNAs, uncovered by the lab of Nobel Laureate, Carolyn Bertozzi, can be used to fight cancer.

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma ...

South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...

Ahead of AACR 2025, Charles River announces updates to its comprehensive portfolio to support the discovery and development of novel oncology drugs.

T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy effectiveness. A research team led by Wolfgang Kastenmüller and Georg ...

With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...

Collaboration partner, Gilead Sciences, to begin Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) study in healthy ...

Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 5.22%, which has investors questioning if this is right time to buy.

Scientists have discovered a promising new way to slow down aging at the cellular level using a special type of whey protein ...

To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

Senti Biosciences, Inc.’s SNTI share price has surged by 6.40%, which has investors questioning if this is right time to sell ...

About Nurix Therapeutics, Inc. Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery ... that regulates activation of multiple immune cell types including T cells ...